Status:
RECRUITING
Novel Regimens in COVID-19 Treatment
Lead Sponsor:
Tanta University
Conditions:
COVID
Corona Virus Infection
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Nitazoxanide has been shown to have a clinical efficacy against severe acute respiratory syndrome coronavirus 2; ivermectin has also demonstrated a remarkable experimental efficacy with a potential to...
Detailed Description
Nitazoxanide has been shown to have a clinical efficacy against severe acute respiratory syndrome coronavirus; ivermectin has also demonstrated a remarkable experimental efficacy with a potential to b...
Eligibility Criteria
Inclusion
- Patients with COVID-19 infection
Exclusion
- Allergy or contraindication to the drugs.
Key Trial Info
Start Date :
May 8 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04382846
Start Date
May 8 2020
End Date
December 1 2030
Last Update
December 4 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University, Assiut University
Tanta, Egypt, 35111
2
Sherief Abd-Elsalam
Tanta, Egypt